Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-05 KURIYEL RALF Senior VP, R&D Grant or award +5,284 20,062
2026-03-05 KURIYEL RALF Senior VP, R&D Grant or award · Stock Option (Right to Buy) +5,669 5,669
2026-03-04 KURIYEL RALF Senior VP, R&D Grant or award +125 14,820
2026-03-04 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −42 $125.84 $5K 14,778
2026-03-02 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −923 $124.97 $115K 14,695
2026-02-27 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −444 $128.73 $57K 15,618
2025-03-03 KURIYEL RALF Senior VP, R&D Grant or award +4,826 16,448
2025-03-03 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −386 $155.38 $60K 16,062
2025-03-03 KURIYEL RALF Senior VP, R&D Grant or award · Stock Option (Right to Buy) +4,542 4,542
2025-02-27 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −391 $156.54 $61K 11,622
2025-02-24 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −275 $164.74 $45K 12,013
2024-08-02 KURIYEL RALF Senior VP, R&D Sale −6,973 $159.36 $1.1M 12,288
2024-08-02 KURIYEL RALF Senior VP, R&D Option exercise +175 $86.10 $15K 12,463
2024-08-02 KURIYEL RALF Senior VP, R&D Sale −175 $158.85 $28K 12,288
2024-08-02 KURIYEL RALF Senior VP, R&D Option exercise · Stock Option (Right to Buy) +175 0
2024-08-01 KURIYEL RALF Senior VP, R&D Sale −4,465 $165.67 $740K 19,261
2024-05-14 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −534 $163.34 $87K 23,726
2024-03-11 KURIYEL RALF Senior VP, R&D Option exercise +1,271 $86.10 $109K 27,777
2024-03-11 KURIYEL RALF Senior VP, R&D Sale −3,517 $193.73 $681K 24,260
2024-03-11 KURIYEL RALF Senior VP, R&D Option exercise · Stock Option (Right to Buy) +1,271 0

Page 1 of 3 · 52 trades